A citation-based method for searching scientific literature

Sungmin Park, Jeong Eon Lee, Jai Min Ryu, Issac Kim, Soo Youn Bae, Se Kyung Lee, Jonghan Yu, Seok Won Kim, Seok Jin Nam. World J Surg 2018
Times Cited: 4







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
158
75

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Akiko Chiba, Tanya L Hoskin, Emily J Hallberg, Jodie A Cogswell, Courtney N Heins, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2016
25
75

Risk-reducing mastectomy for the prevention of primary breast cancer.
Nora E Carbine, Liz Lostumbo, Judi Wallace, Henry Ko. Cochrane Database Syst Rev 2018
93
75

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
50

Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
Alexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, Hester S A Oldenburg, Emiel J Rutgers, Nicola S Russell, Vincent T H B M Smit, Adri C Voogd, Linetta B Koppert, Sabine Siesling,[...]. Ann Surg 2019
21
50

Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis.
Siddhartha Yadav, Ashley Reeves, Sarah Campian, Amy Sufka, Dana Zakalik. Hered Cancer Clin Pract 2017
16
50

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
110
50


Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
Giacomo Montagna, Monica Morrow. Expert Rev Anticancer Ther 2020
4
50

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
Alexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, Sten Cornelissen, Annegien Broeks, Emiel J Rutgers, Vincent T H B M Smit, Cees J Cornelisse, Mike van Beek, Maryska L Janssen-Heijnen,[...]. J Clin Oncol 2016
53
50

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Amanda K Arrington, Stephanie L Jarosek, Beth A Virnig, Elizabeth B Habermann, Todd M Tuttle. Ann Surg Oncol 2009
178
50

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Antonis Valachis, Andreas D Nearchou, Pehr Lind. Breast Cancer Res Treat 2014
67
50

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
Xiao Li, Ran You, Xinwei Wang, Congxin Liu, Zicheng Xu, Jin Zhou, Bin Yu, Ting Xu, Hongzhou Cai, Qing Zou. Clin Cancer Res 2016
72
50

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
T C van Sprundel, M K Schmidt, M A Rookus, R Brohet, C J van Asperen, E J Th Rutgers, L J Van't Veer, R A E M Tollenaar. Br J Cancer 2005
178
50

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
50

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Youlia M Kirova, Dominique Stoppa-Lyonnet, Alexia Savignoni, Brigitte Sigal-Zafrani, Nicolas Fabre, Alain Fourquet. Eur J Cancer 2005
90
50

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
L J Pierce, M Strawderman, S A Narod, I Oliviotto, A Eisen, L Dawson, D Gaffney, L J Solin, A Nixon, J Garber,[...]. J Clin Oncol 2000
180
50

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Bernadette A M Heemskerk-Gerritsen, Matti A Rookus, Cora M Aalfs, Margreet G E M Ausems, Johanna M Collée, Liesbeth Jansen, C Marleen Kets, Kristien B M I Keymeulen, Linetta B Koppert, Hanne E J Meijers-Heijboer,[...]. Int J Cancer 2015
85
50

The hospital anxiety and depression scale.
Anna F Stern. Occup Med (Lond) 2014
195
25

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
25



Hereditary breast cancer: new genetic developments, new therapeutic avenues.
Philippe M Campeau, William D Foulkes, Marc D Tischkowitz. Hum Genet 2008
187
25

The validity of the Hospital Anxiety and Depression Scale. An updated literature review.
Ingvar Bjelland, Alv A Dahl, Tone Tangen Haug, Dag Neckelmann. J Psychosom Res 2002
25


Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?
Jennifer S Gass, Michaela Onstad, Sarah Pesek, Kristin Rojas, Sara Fogarty, Ashley Stuckey, Christina Raker, Don S Dizon. Ann Surg Oncol 2017
19
25

Breast Cancer Epidemiology and Risk Factors.
Kristin Rojas, Ashley Stuckey. Clin Obstet Gynecol 2016
140
25

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
665
25

Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer.
Louise Heiniger, Phyllis N Butow, Joseph Coll, Tracey Bullen, Judy Wilson, Brandi Baylock, Bettina Meiser, Melanie A Price. Fam Cancer 2015
23
25

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
Mark Robson, Tiffany Svahn, Beryl McCormick, Patrick Borgen, Clifford A Hudis, Larry Norton, Kenneth Offit. Cancer 2005
81
25

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.
M H Frost, D J Schaid, T A Sellers, J M Slezak, P G Arnold, J E Woods, P M Petty, J L Johnson, D L Sitta, S K McDonnell,[...]. JAMA 2000
211
25

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer.
Jessica P Gopie, Marc A M Mureau, Caroline Seynaeve, Moniek M Ter Kuile, Marian B E Menke-Pluymers, Reinier Timman, Aad Tibben. Fam Cancer 2013
61
25

Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
Jennifer K Litton, Shannon N Westin, Kaylene Ready, Charlotte C Sun, Susan K Peterson, Funda Meric-Bernstam, Ana M Gonzalez-Angulo, Diane C Bodurka, Karen H Lu, Gabriel N Hortobagyi,[...]. Cancer 2009
25
25

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
193
25




Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer.
Wenche Listøl, Hildegunn Høberg-Vetti, Geir Egil Eide, Cathrine Bjorvatn. Hered Cancer Clin Pract 2017
9
25


Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, Barbara L Weber. J Natl Cancer Inst 2002
461
25

Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.
Iman Haroun, Tracy Graham, Aletta Poll, Ping Sun, Kimberley Hill, Eleanor Weitzner, Steven Narod, Ellen Warner. Breast 2011
16
25

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
120
25


Cost of contralateral prophylactic mastectomy.
Ashish A Deshmukh, Scott B Cantor, Melissa A Crosby, Wenli Dong, Yu Shen, Isabelle Bedrosian, Susan K Peterson, Patricia A Parker, Abenaa M Brewster. Ann Surg Oncol 2014
24
25

Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.
Judy C Boughey, Tanya L Hoskin, Lynn C Hartmann, Joanne L Johnson, Steven R Jacobson, Amy C Degnim, Marlene H Frost. Ann Surg Oncol 2015
40
25

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Rikke Langballe, Lene Mellemkjær, Kathleen E Malone, Charles F Lynch, Esther M John, Julia A Knight, Leslie Bernstein, Jennifer Brooks, Michael Andersson, Anne S Reiner,[...]. Breast Cancer Res 2016
25
25

Increase in contralateral prophylactic mastectomy conversation online unrelated to decision-making.
Rebecca A Marmor, Wenrui Dai, Xiaoqian Jiang, Shuang Wang, Sarah L Blair, Jina Huh. J Surg Res 2017
3
33


Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Anne S Reiner, Charles F Lynch, Julia S Sisti, Esther M John, Jennifer D Brooks, Leslie Bernstein, Julia A Knight, Li Hsu, Patrick Concannon, Lene Mellemkjær,[...]. Breast Cancer Res 2017
18
25

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
Kristi D Graves, Beth N Peshkin, Chanita H Halbert, Tiffani A DeMarco, Claudine Isaacs, Marc D Schwartz. Breast Cancer Res Treat 2007
43
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.